Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998)

(2013) R. B. Keus et al.   ANNALS OF ONCOLOGY

Desmoid: The Role of Local Therapy In an Era of Systemic Options

(2013) Brian E. Walczak et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study

(2013) Stephen X. Skapek et al.   PEDIATRIC BLOOD & CANCER

The treatment of desmoid tumors: a stepwise clinical approach

(2012) S. Bonvalot et al.   ANNALS OF ONCOLOGY

IgG4-Related Disease

(2012) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)

(2011) D. Garbay et al.   ANNALS OF ONCOLOGY

Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors

(2011) A. M. Carothers et al.   CANCER RESEARCH

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

(2011) M. M. Gounder et al.   CLINICAL CANCER RESEARCH

Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation

(2011) Sébastien Salas et al.   JOURNAL OF CLINICAL ONCOLOGY

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

(2010) N. Penel et al.   ANNALS OF ONCOLOGY

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

(2010) R. Chugh et al.   CLINICAL CANCER RESEARCH

Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

(2009) Marco Fiore et al.   ANNALS OF SURGICAL ONCOLOGY

Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient

(2009) Sylvie Bonvalot et al.   ANNALS OF SURGICAL ONCOLOGY

Desmoid-type fibromatosis: What works best?

(2009) Chiara Colombo et al.   EUROPEAN JOURNAL OF CANCER

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

(2009) Anastasia Constantinidou et al.   EUROPEAN JOURNAL OF CANCER

Desmoid tumors: need for an individualized approach

(2009) Eelco de Bree et al.   Expert Review of Anticancer Therapy

Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors

(2009) Jennifer L. Kujak et al.   SKELETAL RADIOLOGY

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

(2008) Alexander J.F. Lazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Long-Term Outcomes for Desmoid Tumors Treated With Radiation Therapy

(2008) B. Ashleigh Guadagnolo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients

(2007) S. Bonvalot et al.   EJSO